Learn about the 2011 Safe Cosmetics Act and what implications it may have for the registration, labelling, and compliance of your products on the US market.

Learn about the 2011 Safe Cosmetics Act and what implications it may have for the registration, labelling, and compliance of your products on the US market.
The EU Commission has published a new legislative framework package for the marketing and advertising of CE marked products on the European market.
The Obelis cosmetic regulatory team will present an introduction to the new EU cosmetics regulation at the Indie Beauty Network event in October 2011.
The European Association of Notified Bodies for Medical Devices has published a new code of conduct in response to new EU medical device regulations.
Obelis announce Tel-Aviv workshop to prepare manufacturers for new EU cosmetics regulation and safety assessment reporting system (toxicological assessment).
Following a new decree, all Class I medical devices must be registered with the Italian Ministry of Health. This will not apply to manufacturers with an EC rep.
Find out the definition of an animal by-product and what EU legislative guidelines apply to medical and cosmetic products containing them within the EU market.
The 2010 Obelis International Offices Convention was held in November to discuss a range of EU-wide compliance and regulatory topics.
The two-day EU regulatory workshop included sessions on developments in medical device legislation and manufacturer obligations for the European market.
Obelis has launched its new International Offices and will be hosting EROMED at its home offices in Brussels, Belgium.